{"id":20001,"date":"2020-06-22T17:48:27","date_gmt":"2020-06-22T15:48:27","guid":{"rendered":"https:\/\/www.satt.fr\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/"},"modified":"2020-06-22T17:48:27","modified_gmt":"2020-06-22T15:48:27","slug":"signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/","title":{"rendered":"Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura"},"content":{"rendered":"<p><strong>La startup Signia Therapeutics,\u00a0boost\u00e9e par PULSALYS, a annonc\u00e9 l\u2019obtention d\u2019une subvention d\u2019un montant de 2,38M\u20ac de la Commission Europ\u00e9enne dans le cadre de l\u2019appel \u00e0 projets \u00ab EIC Accelerator Phase 2 \u00bb (Instrument SME), pour le d\u00e9veloppement de sa plateforme SIGNATURA\u00ae d\u00e9di\u00e9e au repositionnement de m\u00e9dicaments.<\/strong><\/p>\n<p><span style=\"color: #ff6600;\"><strong>Un financement qui vient consacrer des \u00e9tapes majeures franchies<\/strong><\/span><\/p>\n<p>La plateforme SIGNATURA\u00ae mise au point par Signia Therapeutics a d\u00e9j\u00e0 permis l\u2019identification et la validation pr\u00e9cliniques de plusieurs m\u00e9dicaments pour leur repositionnement dans le traitement des infections respiratoires, en particulier dans les formes de grippe s\u00e9v\u00e8res. Le financement europ\u00e9en \u00ab H2020 EIC Accelerator \u00bb permettra d\u2019acc\u00e9l\u00e9rer tr\u00e8s significativement le d\u00e9veloppement de la plateforme SIGNATURA\u00ae pour la validation de mol\u00e9cules antivirales de nouvelle g\u00e9n\u00e9ration.<\/p>\n<p>Dans le contexte actuel de pand\u00e9mie, Signia Therapeutics a d\u00e9montr\u00e9 sa force de r\u00e9action rapide en \u00e9tant en mesure de valider dans ses mod\u00e8les pr\u00e9cliniques pr\u00e9dictifs un candidat m\u00e9dicament contre le SARS-CoV-2 trois semaines apr\u00e8s avoir eu acc\u00e8s \u00e0 des \u00e9chantillons de patients COVID-19. Le d\u00e9p\u00f4t de deux demandes de brevets et la soumission de quatre articles scientifiques t\u00e9moignent de la qualit\u00e9 de sa recherche et de sa capacit\u00e9 de mobilisation.<\/p>\n<p>En consacrant l\u2019excellence scientifique de la plateforme SIGNATURA\u00ae, ce financement europ\u00e9en permettra d\u2019acc\u00e9l\u00e9rer la croissance du portefeuille de Signia Therapeutics pour positionner l\u2019entreprise comme un leader dans le domaine du repositionnement de m\u00e9dicaments pour de nouvelles indications th\u00e9rapeutiques contre les infections virales respiratoires.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La startup Signia Therapeutics, boost\u00e9e par PULSALYS, a annonc\u00e9 l\u2019obtention d\u2019une subvention d\u2019un montant de 2,38M\u20ac de la Commission Europ\u00e9enne dans le cadre de l\u2019appel \u00e0 projets \u00ab EIC Accelerator Phase 2 \u00bb (Instrument SME), pour le d\u00e9veloppement de sa plateforme SIGNATURA\u00ae d\u00e9di\u00e9e au repositionnement de m\u00e9dicaments.<\/p>\n","protected":false},"author":24,"featured_media":19430,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,568,604],"tags":[],"class_list":["post-20001","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-successstories-en","category-startup-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sylvain DUC\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/\"},\"author\":{\"name\":\"Sylvain DUC\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/d6cfecbabebe684202068d45b736deca\"},\"headline\":\"Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura\",\"datePublished\":\"2020-06-22T15:48:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/\"},\"wordCount\":297,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/05\/Signia.png\",\"articleSection\":[\"News\",\"Success Stories\",\"Start-up\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/\",\"url\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/\",\"name\":\"Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/05\/Signia.png\",\"datePublished\":\"2020-06-22T15:48:27+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/d6cfecbabebe684202068d45b736deca\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/05\/Signia.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/05\/Signia.png\",\"width\":1271,\"height\":707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/d6cfecbabebe684202068d45b736deca\",\"name\":\"Sylvain DUC\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/sylvain\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/","twitter_misc":{"Written by":"Sylvain DUC","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/"},"author":{"name":"Sylvain DUC","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/d6cfecbabebe684202068d45b736deca"},"headline":"Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura","datePublished":"2020-06-22T15:48:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/"},"wordCount":297,"image":{"@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/05\/Signia.png","articleSection":["News","Success Stories","Start-up"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/","url":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/","name":"Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/05\/Signia.png","datePublished":"2020-06-22T15:48:27+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/d6cfecbabebe684202068d45b736deca"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/05\/Signia.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/05\/Signia.png","width":1271,"height":707},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/signia-therapeutics-boostee-par-pulsalys-obtient-un-financement-europeen-de-238me-qui-vient-accelerer-le-developpement-de-sa-plateforme-signatura\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Signia Therapeutics, boost\u00e9e par PULSALYS, obtient un financement europ\u00e9en de 2,38M\u20ac qui vient acc\u00e9l\u00e9rer le d\u00e9veloppement de sa plateforme Signatura"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/d6cfecbabebe684202068d45b736deca","name":"Sylvain DUC","url":"https:\/\/www.satt.fr\/en\/author\/sylvain\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/20001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=20001"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/20001\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/19430"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=20001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=20001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=20001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}